Improved anti-HPV immunogens and nucleic acid molecules that encode them aredisclosed.Pharmaceutical composition, recombinant vaccines comprising and liveattenuated pathogensare disclosed as well methods of inducing an immune response in an individualagainst HPVare disclosed.